{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:41:21Z","timestamp":1787240481585,"version":"build-2736575974"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to characterize the clinical and genetic spectrum of dynamin 1-like gene (\n                      <jats:italic>DNM1l<\/jats:italic>\n                      )-associated disorders and to investigate genotype-phenotype correlations in the largest integrated cohort reported to date.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical and genetic data from eleven Chinese patients with\n                      <jats:italic>DNM1l<\/jats:italic>\n                      variants were prospectively collected between April 2020 and May 2025. In addition, a comprehensive review of all published cases was performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 66 cases were analyzed, including 11 newly reported Chinese patients and 55 previously published cases. The most common clinical manifestations were developmental delay (89.4%), epilepsy (66.7%), dystonia (53.0%), ataxia (21.2%), and failure to thrive (18.2%). Abnormal neuroimaging (80.3%) and electroencephalogram (EEG) abnormalities (78.0%) were also frequent. Domain-specific analyses demonstrated that, compared with GTPase domain variants (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915), autosomal dominant middle domain variants (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200943) were associated with significantly higher risks of epilepsy, status epilepticus, cerebral atrophy, and poorer survival, but lower rates of peripheral neuropathy and ataxia (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). Nine patients with middle domain variants exhibited rhythmic high-amplitude delta with superimposed (poly)spikes (RHADS) on EEG. Within the middle domain subgroup, 67.4% developed childhood-onset status epilepticus, whereas the remaining 32.6% presented with infantile encephalopathy without status epilepticus, a phenotype associated with significantly higher mortality and earlier death (both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). All 21 patients (100%) with the p.Arg403Cys hotspot variant experienced status epilepticus. The most severe phenotype was observed in two siblings with biallelic truncating variants, both of whom died in the neonatal period. Further cases are required to confirm statistically associations between variant type and clinical severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study provides the largest clinical and genetic characterization of\n                      <jats:italic>DNM1L<\/jats:italic>\n                      associated disorders to date and establishes genotype-phenotype correlations stratified by protein domain. The identification of RHADS as a distinctive EEG signature highlights its potential utility as a biomarker for specific clinical and genetic subgroups. Validation in larger, independent cohorts is necessary.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2025.1672700","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:22:38Z","timestamp":1761805358000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and genetic characterization of DNM1l-related disorders: insights into genotype\u2013phenotype correlations"],"prefix":"10.3389","volume":"13","author":[{"given":"Xu","family":"Manting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiaodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1091\/mbc.12.8.2245","article-title":"Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells","volume":"12","author":"Smirnova","year":"2001","journal-title":"Mol Biol Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ncb1907","article-title":"Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice","volume":"11","author":"Ishihara","year":"2009","journal-title":"Nat Cell Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1083\/jcb.200903065","article-title":"The dynaminrelated GTPase Drp1 is required for embryonic and brain development in mice","volume":"186","author":"Wakabayashi","year":"2009","journal-title":"J Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/ijms26020846","article-title":"de novo DNM1l pathogenic variant associated with lethal encephalocardiomyopathy-case report and literature review","volume":"26","author":"Magistrati","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.3390\/ijms25147782","article-title":"de novo DNM1l mutation in a patient with encephalopathy, cardiomyopathy and fatal non-epileptic paroxysmal refractory vomiting","volume":"25","author":"Berti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"626657","DOI":"10.3389\/fped.2021.626657","article-title":"DNM1l-Related Mitochondrial fission defects presenting as encephalopathy: a case report and literature review","volume":"9","author":"Liu","year":"2021","journal-title":"Front Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"669516","DOI":"10.3389\/fphar.2021.669516","article-title":"Clinical attributes and electroencephalogram analysis of patients with varying Alpers\u2019 syndrome genotypes","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13023-024-03289-5","article-title":"Demographic characteristics, diagnostic challenges, treatment patterns, and caregiver burden of mitochondrial diseases: a retrospective crosssectional study","volume":"19","author":"Zhao","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ped4.12297","article-title":"A brief introduction to the FUTang updating medical REcords (FUTURE) database","volume":"5","author":"Wang","year":"2021","journal-title":"Pediatr Investig"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajhg.2023.11.009","article-title":"Clingen guidance for use of the PP1\/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification","volume":"111","author":"Biesecker","year":"2024","journal-title":"Am J Hum Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/brain\/awx219","article-title":"Mutations in DNM1l, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission","volume":"140","author":"Gerber","year":"2017","journal-title":"Brain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1136\/jmg.2004.025502","article-title":"A third locus for dominant optic atrophy on chromosome 22q","volume":"42","author":"Barbet","year":"2005","journal-title":"J Med Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1056\/NEJMoa064436","article-title":"A lethal defect of mitochondrial and peroxisomal fission","volume":"356","author":"Waterham","year":"2007","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ejhg.2015.243","article-title":"DNM1l-related Mitochondrial fission defect presenting as refractory epilepsy","volume":"24","author":"Vanstone","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpeds.2015.12.060","article-title":"Lethal disorder of mitochondrial fission caused by mutations in DNM1l","volume":"171","author":"Yoon","year":"2016","journal-title":"J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/hmg\/ddw059","article-title":"Missense variants in the middle domain of DNM1l in cases of infantile encephalopathy alter peroxisomes and mitochondria when assayed in Drosophila","volume":"25","author":"Chao","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/ajmg.a.37624","article-title":"Postnatal microcephaly and pain insensitivity due to a de novo heterozygous DNM1l mutation causing impaired mitochondrial fission and function","volume":"170","author":"Sheffer","year":"2016","journal-title":"Am J Med Genet A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/ajmg.a.37721","article-title":"A novel de novo dominant negative mutation in DNM1l impairs mitochondrial fission and presents as childhood epileptic encephalopathy","volume":"170","author":"Fahrner","year":"2016","journal-title":"Am J Med Genet A"},{"key":"B21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/humu.23033","article-title":"Biallelic mutations in DNM1l are associated with a slowly progressive infantile encephalopathy","volume":"37","author":"Nasca","year":"2016","journal-title":"Hum Mutat"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/mds.27021","article-title":"Severe infantile parkinsonism because of a de novo mutation on DLP1 mitochondrial-peroxisomal protein","volume":"32","author":"Diez","year":"2017","journal-title":"Mov Disord"},{"key":"B23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10528-017-9829-2","article-title":"DNM1l variant alters baseline mitochondrial function and response to stress in a patient with severe neurological dysfunction","volume":"56","author":"Hogarth","year":"2018","journal-title":"Biochem Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/0883073818778203","article-title":"de novo DNM1l variant in a teenager with progressive paroxysmal dystonia and lethal super-refractory myoclonic Status epilepticus","volume":"33","author":"Ryan","year":"2018","journal-title":"J Child Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1212\/NXG.0000000000000258","article-title":"de novo DNM1l mutation associated with mitochondrial epilepsy syndrome with fever sensitivity","volume":"4","author":"Ladds","year":"2018","journal-title":"Neurol Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"103625","DOI":"10.1016\/j.ejmg.2019.01.015","article-title":"De-novo mutations in patients with chronic ultra-refractory epilepsy with onset after age five years","volume":"63","author":"McCormack","year":"2020","journal-title":"Eur J Med Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/humu.23729","article-title":"Clinical-genetic features and peculiar muscle histopathology in infantile DNM1l-related mitochondrial epileptic encephalopathy","volume":"40","author":"Verrigni","year":"2019","journal-title":"Hum Mutat"},{"key":"B28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1055\/s-0039-1685217","article-title":"A de novo dominant negative mutation in DNM1l causes sudden onset Status epilepticus with subsequent epileptic encephalopathy","volume":"50","author":"Schmid","year":"2019","journal-title":"Neuropediatrics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1002\/ajmg.a.61371","article-title":"Novel and lethal case of cardiac involvement in DNM1l mitochondrial encephalopathy","volume":"179","author":"Vandeleur","year":"2019","journal-title":"Am J Med Genet A"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1093\/hmg\/ddy287","article-title":"Aberrant Drp1-mediated mitochondrial division presents in humans with variable outcomes","volume":"27","author":"Whitley","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.braindev.2020.12.017","article-title":"Focal status and acute encephalopathy in a 13-year-old boy with de novo DNM1l mutation: video-polygraphic pattern and clues for differential diagnosis","volume":"43","author":"Mancardi","year":"2021","journal-title":"Brain Dev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"604105","DOI":"10.3389\/fped.2021.604105","article-title":"Case report: a novel de novo mutation in DNM1l presenting with developmental delay, ataxia, and peripheral neuropathy","volume":"9","author":"Wei","year":"2021","journal-title":"Front Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/hmg\/ddz211","article-title":"Impaired turnover of hyperfused mitochondria in severe axonal neuropathy due to a novel DRP1 mutation","volume":"29","author":"Longo","year":"2020","journal-title":"Hum Mol Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"104134","DOI":"10.1016\/j.ejmg.2020.104134","article-title":"de novo DNM1l variant presenting with severe muscular atrophy, dystonia and sensory neuropathy","volume":"64","author":"Keller","year":"2021","journal-title":"Eur J Med Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e202101284","DOI":"10.26508\/lsa.202101284","article-title":"Novel DNM1l variants impair mitochondrial dynamics through divergent mechanisms","volume":"5","author":"Nolden","year":"2022","journal-title":"Life Science Alliance"},{"key":"B36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1684\/epd.2021.1375","article-title":"Epilepsia partialis continua associated with the p.Arg403Cys variant of the DNM1l gene: an unusual clinical progression with two episodes of super-refractory status epilepticus with a 13-year remission interval","volume":"24","author":"Minghetti","year":"2022","journal-title":"Epileptic Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/s-0043-1771352","article-title":"DNM1l Variant presenting as adolescent-onset sensory neuronopathy, spasticity, dystonia, and ataxia","volume":"21","author":"Wang","year":"2023","journal-title":"J Pediatr Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12887-023-04442-y","article-title":"A novel variant of DNM1l expanding the clinical phenotypic spectrum: a case report and literature review","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Pediatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s10072-024-07974-y","article-title":"Expanding the phenotypic spectrum of DNM1-related disorders: novel GTPase domain variants and their diverse neurological outcomes","volume":"46","author":"Liu","year":"2025","journal-title":"Neurol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1093\/brain\/awy024","article-title":"The expanding neurological phenotype of DNM1l-related disorders","volume":"141","author":"Wangler","year":"2018","journal-title":"Brain J Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"a003673","DOI":"10.1101\/mcs.a003673","article-title":"de novo missense variant in the GTPase effector domain (GED) of DNM1l leads to static encephalopathy and seizures","volume":"5","author":"Assia Batzir","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1672700\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:22:39Z","timestamp":1761805359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1672700\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":41,"alternative-id":["10.3389\/fped.2025.1672700"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1672700","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"article-number":"1672700"}}